FDA Person
Office of the CommissionerJolanna A. Norton
View detailed information about Jolanna A. Norton, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner. Took part in 59 inspections of 58 companies, 2016–2026.
Inspections (59)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 7, 2026 | Yung Shin Pharmaceutical Industry Co., Ltd. | Not classified | #1338914 | |
| April 22, 2026 | Hyland's Consumer Health Inc. | Not classified | Drug Quality Assurance | #1307766 |
| March 12, 2026 | Cardinal Health 414 LLC | Not classified | #1310744 | |
| March 6, 2026 | PETNET Solutions, Inc. | Not classified | Drug Quality Assurance | #1306284 |
| January 30, 2026 | Element Materials Technology Oakland-Concord | OAI | Drug Quality Assurance | #1300524 |
| December 4, 2025 | PETNET Solutions, Inc. | VAI | Drug Quality Assurance | #1294174 |
| August 28, 2025 | Fresenius Kabi USA, LLC | NAI | Drug Quality Assurance | #1291112 |
| August 22, 2025 | Hospira Inc | NAI | Drug Quality Assurance | #1278254 |
| July 3, 2025 | Wedgewood Connect, LLC | VAI | Drug Quality Assurance | #1275280 |
| March 27, 2025 | Apollo Care, LLC | OAI | Drug Quality Assurance | #1268734 |
| February 10, 2025 | STAQ Pharma, Inc. | Not classified | #1262991 | |
| December 13, 2024 | John L. McClellan Memorial Veterans Hospital | Not classified | #1259377 | |
| November 8, 2024 | F.H. Investments Inc. | VAI | Drug Quality Assurance | #1255751 |
| October 4, 2024 | Molecular Imaging Program at Stanford | VAI | Drug Quality Assurance | #1251796 |
| August 19, 2024 | BioMarin Pharmaceutical, Inc. | VAI | Drug Quality Assurance | #1251795 |
| May 31, 2024 | Delpharm Dijon | VAI | Generic Drug Evaluation | #1240699 |
| May 21, 2024 | Zoetis Belgium S.A. | NAI | Pre-Approval Eval. of Animal Drugs and Food Additives | #1247453 |
| March 25, 2024 | Origin Nutraceutical Inc. | Not classified | #1240698 | |
| February 12, 2024 | Gilead Sciences, Inc. | VAI | New Drug Evaluation | #1229435 |
| December 22, 2023 | Daiichi Sankyo Chemical Pharma Co., Ltd. | VAI | Drug Quality Assurance | #1226353 |
Documents (31)
- 483 · Be Well Natural Medicine · May 20, 2022
- 483 · Wedgewood Connect, LLC · December 3, 2021
- 483 · One Way Drug DBA Partell Specialty Pharmacy · November 25, 2019
- 483 · Central Admixture Pharmacy Services, Inc. · August 25, 2023
- 483 · Apollo Care, LLC · March 27, 2025
- EIR · Eli Lilly & Company · January 17, 2020
- 483 · PETNET Solutions, Inc. · December 2, 2025
- 483 · PETNET Solutions, Inc. · December 4, 2025
- 483 · Pyramid Laboratories, Inc. · April 11, 2019
- 483 · Element Materials Technology Oakland-Concord · January 30, 2026
- EIR · Pyramid Laboratories, Inc. · April 11, 2019
- 483 · BioMarin Pharmaceutical, Inc. · August 19, 2024
- 483 · BioMarin Pharmaceuticals Inc. · August 19, 2024
- 483 · Molecular Imaging Program at Stanford · October 4, 2024
- 483 · Pacific BioLabs, Inc. · June 1, 2023
- EIR · C S Bio Co. · February 17, 2022
- EIR · Sever Pharma Solutions · March 31, 2023
- EIR · Alliance Medical Products, Inc. DBA Siegfried Company · February 14, 2019
- 483 · Gilead Sciences, Inc. · February 12, 2024
- 483 · Daiichi Sankyo Chemical Pharma Co., Ltd. · December 22, 2023
- 483 · Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals · January 28, 2020
- EIR · BioMarin Pharmaceutical, Inc. · December 14, 2017
- 483 · Verde Cosmetic Labs, LLC · February 9, 2023
- 483 · EO Products, LLC · November 17, 2020
- 483 · Rx Unlimited Pharmacy · October 21, 2022
- 483 · Logix Biosciences Inc. · September 20, 2021
- 483 · Integrated Health Concepts Inc. · July 23, 2021
- 483 · Delpharm Dijon · May 31, 2024
- 483 · Nissui Corporation · December 15, 2023
- 483 · Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy · September 15, 2022
- 483 · McKesson Corporation Headquarters · July 3, 2018
Frequently inspected with (10)
Kimberly M. Lichter
3 shared
Ayodele I. Ojediran
2 shared
Joseph C. Yen
2 shared
Marcus F. Yambot
Senior Consumer Safety Officer
2 shared
Matthew R. Clabeaux
2 shared
Walden H. Lee
Chemist/Investigator - Pharmaceutical Quality
2 shared
Aaron Weisbuch
1 shared
Alexandra B. Pitkin
Investigator
1 shared
Amanda L. Fyles
investigator
1 shared
Andrew K. Haack
Compliance Officer
1 shared
Related Office
Person Information
Name
Jolanna A. Norton
Title
Investigator
Role
Regulatory Personnel
ID: 5501fea4-4bfd-434c-b2aa-fcf94444f684
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.